Fig. 6From: Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancerThe validation of the risk model for predicting the prognosis of cervical cancer. Survival analysis showing the OS of cervical cancer patients in the CGCI-HTMCP-CC dataset (high-risk group: n = 59; low-risk group, n = 59, A) and the DFS of cervical cancer patients in the GSE44001 dataset (high-risk group: n = 150; low-risk group, n = 150, B). C The AUCs for 12-, 18-, 24-, and 27-month ROC in the CGCI-HTMCP-CC cohort. D The AUCs for 12-, 24-, 36-, 48- and 60-month ROC in the GSE44001 cohort. E Comparison of the predictive ability of the dsRBP signatures with 10 previously reported risk models for cervical cancer. DFS disease-free survivalBack to article page